# Waycen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/waycen

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.waycen.com/
- Total disclosed funding: $2.7M
- Latest round: Series A (Feb 24, 2021)
- Investors on record: 4

## About

Based in Seoul, South Korea, and founded in 2019, Waycen Inc. operates as a company that focuses on medical AI technology, developing I-driven tools for the healthcare industry, with a specific emphasis on instant image interpretation and large-scale medical data. The company was founded by its CEO, Kyungnam (James) Kim. In October 2024, Waycen, Inc. raised venture funding from SparkLabs Accelerator.

The company’s key offering is WAYMED Cough, which is a mobile application enabling users to monitor respiratory health using only a smartphone. This app analyzes cough, breath, and voice sounds to provide actionable insights, making respiratory health management accessible anytime, anywhere. It also integrates with IoT devices and healthcare institutions, facilitating data sharing for digital health services. The firm’s other innovation, H-AID, is a real-time patient monitoring platform that collects and analyzes life-log data such as biometrics, activity levels, and medication adherence. This platform is designed for use in hospitals and remote care settings. H-AID supports healthcare professionals by delivering insights to personalize treatment plans and improve outcomes.

## Funding rounds

- Series A, Feb 24, 2021, $2.7M — Samho Green Investment, ID Ventures, Creation Investment Advisory, T Investment

## Investors

- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series A
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Series A
- Creation Investment Advisory (https://capitalatlas.ai/funds/creation-investment-advisory) — Series A
- T Investment (https://capitalatlas.ai/funds/t-investment) — Series A